The impact of a stewardship programme on outcomes in patients admitted with community-acquired pneumonia

M. Fally (Hellerup, Denmark), S. Israelsen (Copenhagen, Denmark), B. Tarp (Silkeborg, Denmark), T. Benfield (Copenhagen, Denmark), P. Ravn (Hellerup, Denmark)

Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Session: Antibiotic therapy for pneumonia and pleural infections
Session type: Oral Presentation
Number: 4668
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Fally (Hellerup, Denmark), S. Israelsen (Copenhagen, Denmark), B. Tarp (Silkeborg, Denmark), T. Benfield (Copenhagen, Denmark), P. Ravn (Hellerup, Denmark). The impact of a stewardship programme on outcomes in patients admitted with community-acquired pneumonia. 4668

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


ERS guideline compliant antibiotics among hospitalized patients with Community-acquired pneumonia on the ward service
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018




Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005

Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012


The impact of 2016 guideline on clinical practice for the management of hospital-acquired and ventilator-associated pneumonia in Taiwan
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018


The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
Source: Eur Respir J 2011; 38: 878-887
Year: 2011



Implementation of ERS guidelines for the management of adult community-acquired pneumonia in a primary care hospital
Source: Eur Respir J 2001; 18: Suppl. 33, 503s
Year: 2001

Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia
Source: Eur Respir J 2006; 27: 1210-1216
Year: 2006



The cost of inpatient care in community-acquired pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 258s
Year: 2005

Cost minimization for community-acquired pneumonia management in Belarussian hospital from implementation of clinical guidelines
Source: Eur Respir J 2005; 26: Suppl. 49, 258s
Year: 2005

Timing of previous hospitalizations impacts outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

On improving assessment of in-hospital mortality and ICU admisison in community-acquired pneumonia patients by using the e-CURB
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012

The impact of empiric antibacterial therapy on mortality for patients hospitalized with community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 733s
Year: 2006

Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009

The impact of a delay in intensive care unit admission for community-acquired pneumonia
Source: Eur Respir J 2010; 36: 826-833
Year: 2010



The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007


Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009


A worldwide perspective of the level of compliance with guidelines in hospitalized patients with community-acquired pneumonia: results from the CAPO cohort international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Determinants of performance of indicators on antibiotic use in community-acquired pneumonia (CAP) at hospitals
Source: Eur Respir J 2005; 26: Suppl. 49, 638s
Year: 2005